Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Pump's daily trading recs, emphasis on short selling -- Ignore unavailable to you. Want to Upgrade?

To: Mark L. who wrote (5410)	8/24/2001 11:22:38 PM
From: Patzack	Respond to of 6873

Baaa, don't you worry abt our shoRt position please

To: Mark L. who wrote (5410)	8/25/2001 2:02:20 AM
From: lifeisgood	Respond to of 6873

I would urge you to do a little more research. I have and my conclusions are that this drug has never demonstrated any significant real-world benefit. Statistically significant lab findings are not difficult to generate with sufficient sample sizes. Clinically significant results are much more difficult and this is where Pleconaril has always come up short. Fair disclosure, I'm short. best... LIG

To: Mark L. who wrote (5410)	8/27/2001 2:16:26 AM
From: Mud	Respond to of 6873

Thanks for the note on VPHM I am short only a few hundred shares, mainly because this area is where I have done it before and they are still carrying a considerable cash flow problem.. They have also put out bogus news before.Besides, TA does look very good here for a short. I truly wish you luck on your long, and will say short this one on a speculation basis only. But if the management follows its old ways this will be a money maker.. (Be it a small one-every bit counts) Good trading to you Mark L.